Article: Famvir(R) Effective For Suppression of Recurrent Genital Herpes, New Study Shows

ALBUQUERQUE, N.M., Feb. 10 /PRNewswire/ -- According to a new study, Famvir(R) (famciclovir, SmithKline Beecham) twice daily is an effective treatment for patients who suffer from frequent genital herpes outbreaks. After four months of treatment, 90 percent of patients who were administered 250 mg of Famvir twice daily were recurrence-free compared to only 48 percent of placebo-treated patients. The study results were published today in the Archives of Internal Medicine.

"For patients suffering from frequent genital herpes episodes, treatments that completely suppress or significantly reduce the number of recurrent outbreaks are critical. While once a day ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!